Drug Testing: Technologies and Global Markets

Report Code: PHM013E

Publish Date: Jul 2008

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for DOA testing increased from $1.9 billion in 2007 to an estimated $2.0 billion by the end of 2008. It should reach $2.6 billion in 2014, for a compound annual growth rate (CAGR) of 4.6%.
  • The U.S. testing market segment generated the largest share of revenues with $1.4 billion in 2007. This is expected to reach $1.5 billion in 2008 and $2.0 billion in 2014, for a CAGR of 5.2%.
  • The European Union had the second largest market segment with $365.2 million in sales in 2007. This is expected to grow at a CAGR of 2.9% to reach $374.2 million in 2008 and $445.9 million in 2014.

INTRODUCTION  

STUDY GOAL AND OBJECTIVES
 
The purpose of this study is to analyze the market for drugs of abuse (DOA) testing globally and to provide market, technology, and revenue forecasts for the period 2008 to 2014. This report also analyzes the global environment related to regulations, national level policies, and legislation in several parts of the world that affect DOA testing markets.
 
This BCC report provides an in-depth look at DOA testing markets, which had sales of more than $1.9 billion in 2007. Future growth prospects of this market by various sample matrices have been analyzed based on market dynamics, technology efficacies, and regulatory factors. Regional analysis of the industry in terms of current and future trends of drug abuse and testing practices in important regions has been presented in the study. The report also identifies key market players with significant market shares, analyzes current and future strategies of these companies that will have an impact in the market, and analyzes future growth trends. Key companies participating in this market are profiled.
 
This report also analyzes the current and possible future legislations affecting the market in the U.S. and other countries, and examines the influence of these acts in the development of the industry. Finally, several testing technologies have been discussed and testing trends with respect to various sample matrices have been presented in the report, identifying the likely trends in the foreseeable future.
 
REASONS FOR DOING THE STUDY
 
BCC published a comprehensive report on DOA testing in 2002. Since then, the DOA industry has undergone many noteworthy changes. One key factor that was instrumental in these changes is the extensive growth of narcotics markets and consequently governmental initiatives and efforts to combat and eradicate these markets, not only in favor of crimes related to the narcotics, but also to ensure quality in the social structure within the nation. This has led the regulatory framework in several countries to undergo changes and evolve over time to address drug production and trafficking.
 
This report analyzes the current and emerging trends in the market. In addition, it also analyzes regulatory issues for several countries related to drug trafficking and abuse that illustrate the nation’s stand on narcotics and its awareness among the masses that potentially affects DOA testing sales within these markets. 
 
INTENDED AUDIENCE
 
This study offers insight into the successful strategies adopted by companies that helped them improve their market shares in the DOA testing markets. High-growth markets in terms of geographic regional growth trends for various sample matrices for drug of abuse testing are identified. Strategies adopted by big in vitro diagnostic companies as well as small innovative diagnostic companies entering the market have been identified. These detailed analyses are targeted to assist developers and decision makers of healthcare diagnostics companies. The report includes detailed analyses of the regulatory factors that have been instrumental in driving the industry in developed countries. This is especially suitable for legislators involved in government policy development programs. Technology trend analysis gives an overview of successful technologies, which is helpful for research managers in charge of project identification and development. 
 
SCOPE OF REPORT
 
This report contains: 
  • An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
  • Drug abuse statistics in key regions.
  • Analysis of regulatory environments in North, South and Central America, Europe, and Asia Pacific, and country-wise summaries of national legislation and policies.
  • Drug of abuse testing markets with respect to testing approaches and sample matrices.
  • Technology trends in the drug of abuse testing market.
  • Leading players in the market and their key products.
  • Sales projections through 2014 for drug of abuse testing markets by sample matrix and geographic regions.
  • Analysis of leading companies and their successful strategies.
METHODOLOGY
 
The base year of this study is 2007. Market figures are based on the revenues at the manufacturer’s level and are projected at 2007 dollar value (i.e., inflation is not computed into the projection figures). Forecasts are mainly based on the projections of the marketers. Growth of competing products, technologies, drug of abuse growth trends, government policies, and trends in the in vitro diagnostics (IVD) market have also been considered for estimating the future growth trends.
 
Data to prepare this study was derived from regulatory agencies, trade literature, patient support groups, and annual reports of companies and industry related databases. In addition, discussion with product managers of diagnostic companies, research executives, academic researchers, and government agency spokespersons have been conducted for gaining insights about the market, strategies, and future trends.
 
INFORMATION SOURCES
 
The information and analysis presented in this report are based on an extensive survey of the DOA industry as well as a detailed examination of published literature and reports obtained from regulatory authorities, medical research institutions, trade associations, and national and world health organizations. Key information from the literature was used to obtain expert opinions on commercial potential and market sizes from industry professionals.
 
AUTHOR’S CREDENTIALS
 
Syamala Ariyanchira was involved in chemical and pharmaceutical research for 7 years before moving into industry analysis. For the past 5 years, she has been actively involved in chemical and healthcare industry analysis. She has a PhD in chemistry and post-doctoral experience in biophysics. 
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Drug Testing: Technologies and Global Markets128Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY2Free
Chapter- 3: OVERVIEW19Free
Chapter- 4: DRUGS OF ABUSE TESTING PRACTICES27Free
Chapter- 5: GOVERNMENT REGULATIONS: DRUG TRAFFICKING AND DRUG ABUSE TESTING33Free
Chapter- 6: GLOBAL DRUGS OF ABUSE TESTING MARKET BY SAMPLE MATRIX10Free
Chapter- 7: WORLDWIDE INDUSTRY STRUCTURE22Free
Chapter- 8: PATENT ANALYSIS5Free
Chapter- 9: APPENDIX6Free
Published - Jul-2002| Analyst - Ruth Scolnick| Code - PHM013D

Report Highlights

  • Drugs of abuse testing sales will reach $1.6 billion in 2007, rising at an AAGR (average annual growth rate) of 4.7%.
  • Sales in the U.S. are expected to reach $996 million in 2002 and forecasted to grow to $1.3 billion in 2007 at an AAGR of 5.4%.
  • Sales in Europe expected to be $291 million in 2002 and forecasted to grow at an AAGR of 1.8% to approximately $318 million in 2007.
  • The number of different places and applications, such as a workplace, drug court, hospital, and school, for drug testing, with blood, hair, oral fluid, sweat or urine samples, reflects the need for a variety of drug testing services and the versatility of drug testing technology.

Related Reports

Recent Reports

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

ESG Trends in Chemical Industry

Published - Dec 2022 | Publisher - BCC Publishing | Code - ENV056A

This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the  chemical industry.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Smartphone-Based Patient Monitoring: Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - HLC285A

The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.

Seawater and Brackish Water Desalination

Published - Nov 2022 | Publisher - BCC Publishing | Code - MST052E

The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Drug Testing: Technologies and Global Markets
Customize Report